MAF
MAF (MAF bZIP transcription factor, also known as c-MAF) is a nuclear, DNA-binding transcription factor of the Maf subfamily of bZIP proteins. It can activate or repress target genes and has roles in lens, immune and cartilage development. Browse Assay Genie's current range of MAF research reagents below, or read on for the biology behind the target.
MAF is a leucine zipper-containing transcription factor that binds DNA as a homodimer or as a heterodimer. Depending on the binding site and its binding partner, it acts as a transcriptional activator or repressor. In lens fibre cells it recruits the coactivators CREBBP and/or EP300 to crystallin promoters, up-regulating crystallin genes during differentiation, and it binds the T-MARE (Maf response element) sites of alpha- and beta-crystallin promoters.
Its targets extend beyond the lens. MAF activates IL4 expression in T helper 2 (Th2) cells and increases T-cell susceptibility to apoptosis by interacting with MYB and decreasing BCL2 expression. With PAX6 it strongly transactivates the glucagon promoter through the G1 element. In endothelial cells it activates the CD13 proximal promoter, whereas in early myelopoiesis it represses CD13 by affecting the cooperative interaction of ETS1 and MYB. It also contributes to initial chondrocyte terminal differentiation and the disappearance of hypertrophic chondrocytes during endochondral bone development. When overexpressed, it represses anti-oxidant response element (ARE)-mediated transcription, and it can bind ARE sites in detoxifying enzyme gene promoters. UniProt notes that it acts either as an oncogene or as a tumour suppressor, depending on cell context.
The MAF gene belongs to the Large MAF bZIP transcription factor family, and the protein is a member of the bZIP family, Maf subfamily. The HGNC previous name was v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog; the mouse ortholog is Maf. Defects in the gene cause juvenile-onset pulverulent cataract and congenital cerulean cataract 4 (CCA4). Two transcript variants encoding different isoforms have been described.
MAF drives crystallin gene expression in lens fibre cells, and defects in the gene cause pulverulent and cerulean cataract.
MAF activates IL4 in Th2 cells and modulates T-cell susceptibility to apoptosis through MYB and BCL2.
MAF is involved in chondrocyte terminal differentiation and the loss of hypertrophic chondrocytes during endochondral bone development.
MAF can behave as an oncogene or tumour suppressor depending on cell context, making it a subject for transcriptional studies.
MAF is a nuclear transcription factor that can activate or repress gene expression depending on its binding site and partner. It supports lens fibre cell development, activates IL4 in Th2 cells, and contributes to chondrocyte terminal differentiation during endochondral bone development.
MAF is also known as c-MAF, and its UniProt protein name is Transcription factor Maf. The previous HGNC name was v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog. Two transcript variants encoding different isoforms have been reported for the gene.
Defects in the MAF gene cause juvenile-onset pulverulent cataract and congenital cerulean cataract 4 (CCA4). Orthologs exist in mouse (Maf) and rat (Mmd). Check the datasheet of any product for its validated reactivity.
Transcriptional coactivators, partner transcription factors and downstream targets that work with MAF in lens, immune and cartilage biology.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O75444; product specifications from Assay Genie datasheets.